| CAT No: | CL-TFC-89 |
| CAS No: | NA |
| Mol.F: | C16H20N6O |
| Mol.Wt.: | 312.4 |
| Rel. Cas No: | |
| Chemical Name: | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1) |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Tofacitinib Citrate Recamic Mixture is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Tofacitinib Citrate Recamic Mixture is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1)Country of Origin: India Product Category: Impurity Reference StandardAPI NAME: Tofacitinib Molecular Formula: C16H20N6O
Molecular Weight: 312.4
Storage: Store in a cool, dry place.
| Product Name: | Tofacitinib Citrate Recamic Mixture |
| CAS No: | |
| Mol.F.: | C16H20N6O |
| Mol.Wt.: | 312.4 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: